Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature
- Author(s): Saleh, Maleck;
- Reedy, Matthew;
- Torok, Helen;
- Weaver, Joshua
- et al.
Published Web Locationhttps://doi.org/10.5070/D3274053155
Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters. Most cases are treated with a combination of systemic and topical corticosteroids as well as other immunomodulatory drugs. Dupilumab is a fully human monoclonal antibody that acts as an antagonist against IL4Ra traditionally used in the treatment of atopic dermatitis. We present an 80-year-old man with moderate to severe bullous pemphigoid successfully treated with dupilumab.